Amgen’s peek at its GLP-1 drug trial results heightens competition in obesity market Yahoo FinanceAmgen goes all in on injectable obesity drug as it scraps early-stage pill STATAmgen Is ‘Very Encouraged’ With Obesity Drug; Shares Near Record High Investor’s Business DailyAmgen stock soars on weight loss injection progress as Novo Nordisk, Eli Lilly shares slide CNBCNovo Slides as Amgen Fuels Obesity Drug Competition Fears Bloomberg